RedHill Biopharma (RDHL) Return on Capital Employed Growth (3y) (2017 - 2023)
RedHill Biopharma (RDHL) Return on Capital Employed Growth (3y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1,301.00 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 353.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 480.00 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1,342.00 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 2,112.00 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 626.00 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1,788.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1,809.00 |
| 10 | RedHill Biopharma | 142.34 Mn | 142.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -27,742.00 |
| Dec 31, 2022 | 1,588.00 |
| Jun 30, 2022 | -910,516.00 |
| Dec 31, 2021 | -16,210.00 |
| Jun 30, 2021 | -9,033.00 |
| Dec 31, 2020 | -6,095.00 |
| Dec 31, 2019 | 3,844.00 |
| Mar 31, 2018 | 5,981.00 |
| Dec 31, 2017 | 6,605.00 |